Editorial
 GRANTING CL FOR DASATINIB   
 Wednesday, August 20, 2014 
 The Department of Industrial Policy and Promotion (DIPP) last week once again approached the health ministry with the request to grant a compulsory license (CL) for the cancer drug, Dasatinib, on the ground that it is unaffordable to several thousands of cancer patients in the country. 
  Past Editorial...  
TODAY'S NEWS
11:00  [IST]US FDA granted marketing nod for zinc transporter 8 autoantibody test to diagnose type 1diabetes
10:00  [IST]Baxter's phase 3 study of BAX 855 for treatment of haemophilia A meets primary endpoint
09:00  [IST]Eliquis approved in US to treat DVT & PE and for reduction in risk of recurrent DVT and PE following initial therapy
more news >>
TOP NEWS
08:00  [IST]NPPA fixes/revises ceiling and retail prices of 56 formulation packs
08:00  [IST]Centre to set up a unit of AIIMS in Karnataka soon to make up shortage of doctors
08:00  [IST]Govt should make screening mandatory to detect congenital hypothyroidism: Healthcare experts
08:00  [IST]Karnataka govt yet to disburse Rs.10 cr for dedicated unit at IGICH to treat lysosomal storage disorder
08:00  [IST]Pharmexcil to send business delegation to Ireland in October to explore business opportunities
08:00  [IST]Practo eyes global healthcare market with SAAS to digitise medical info & patient history
more news >>
YESTERDAY'S NEWS
18:00  [IST]Study reports death toll from chronic diseases rising in Africa
17:00  [IST]Boston completes patient enrollment in phase IIb study of BTI-320 in US to treat type 2 diabetes
16:40  [IST]Merck Serono India wins five awards at CMO Asia 2014
16:30  [IST]Menzies Aviation Bobba Cargo Terminal opens an exclusive Pharma Cold Zone at Bengaluru airport
16:00  [IST]Suzhou Amerigen Pharma launches generic mecobalamin in Chinese market
15:00  [IST]NIH research awards $19.4 million to address multiple chronic conditions
more news >>
INTERVIEW  
KSPC works out strategies with Kerala govt to enforce Section 42 of Pharmacy Act in State
B Rajan, president of KSPC
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the union health ministry's recent move to increase the number of drugs covered under the national list of essential medicines (NLEM) justified?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |